[
    [
        {
            "time": "2021-07-01",
            "original_text": "通化东宝：与上海药明康德深化创新药项目合作，丰富内分泌领域研发管线",
            "features": {
                "keywords": [
                    "通化东宝",
                    "药明康德",
                    "创新药",
                    "内分泌",
                    "研发管线"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "通化东宝：与上海药明康德深化创新药项目合作，丰富内分泌领域研发管线",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-30",
            "original_text": "上半年，港股中国石油股份累计上涨65%，招商银行涨35%，药明康德涨44%，安踏体育涨49%，李宁涨77%，碧桂园服务涨61%，中远海控涨110%。",
            "features": {
                "keywords": [
                    "药明康德",
                    "股票上涨",
                    "港股",
                    "涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "医药",
                    "消费品"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上半年，港股中国石油股份累计上涨65%，招商银行涨35%，药明康德涨44%，安踏体育涨49%，李宁涨77%，碧桂园服务涨61%，中远海控涨110%。",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "业内：药明康德减持药明巨诺或与竞品定价不及预期有关 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "减持",
                    "药明巨诺",
                    "竞品定价"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "业内：药明康德减持药明巨诺或与竞品定价不及预期有关 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "RNAi+创新抗病毒疗法，乙肝组合疗法有望下半年启动临床试验",
            "features": {
                "keywords": [
                    "RNAi",
                    "抗病毒疗法",
                    "乙肝",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "RNAi+创新抗病毒疗法，乙肝组合疗法有望下半年启动临床试验",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "针对Delta等十多种变异病毒株，mRNA疫苗最新中和效力结果出炉",
            "features": {
                "keywords": [
                    "mRNA疫苗",
                    "Delta变异株",
                    "中和效力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "针对Delta等十多种变异病毒株，mRNA疫苗最新中和效力结果出炉",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "药明康德出手：被曝减持兄弟公司配售2300万股 套现约6.7亿 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "减持",
                    "兄弟公司",
                    "套现"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德出手：被曝减持兄弟公司配售2300万股 套现约6.7亿 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]